Tyblume Kit
Product Images NDC 0642-7471

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tyblume (NDC 0642-7471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exeltis Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Levonorgestrel 01)

A horizontal bar chart depicting the number of women with a blood clot out of 10,000 women years (WY) across four groups: Non-Pregnant Non-COC users (range 1 to 5), COC users (range 3 to 9), Pregnancy (range 5 to 20), and Postpartum (12 weeks only) with the highest range from 40 to 65.*

FDA Label Image

Chemical Structure (Levonorgestrel 02)

Chemical structure diagram showing the molecular structure of the active ingredient Levonorgestrel, a component of the drug Tyblume (Levonorgestrel and Ethinyl Estradiol). The structure includes multiple rings, hydroxyl (OH) group, and other characteristic features of this steroid hormone.*

FDA Label Image

Chemical Structure (Levonorgestrel 03)

Chemical structure diagram showing the steroid backbone with hydroxyl and ethynyl functional groups, consistent with the active ingredients levonorgestrel and ethinyl estradiol in the product Tyblume.*

FDA Label Image

Image (Levonorgestrel 04)

An illustration depicting methods of birth control arranged on a vertical scale representing pregnancy rates per 100 women per year, from fewer than 1 to 85 or more. The scale categorizes methods into groups: implants, injections, intrauterine devices, and sterilization at the top (fewer pregnancies); birth control pills, skin patch, and vaginal ring in the next tier; condoms and diaphragm below that; then no sex during the most fertile days, spermicide, and withdrawal; and no birth control at the bottom (most pregnancies).*

FDA Label Image

Figure A (Levonorgestrel 05)

Tyblume oral contraceptive kit label showing a 28-day pill schedule arranged in four weekly rows. Days 1 through 21 are represented by white circles for active pills, and days 22 through 28 are pink circles labeled as placebo. Arrows indicate the daily progression, with the start day noted and space for placing days of the week labels. The label includes the Tyblume brand name and logo on the right side.*

FDA Label Image

Figure B (Levonorgestrel 06)

An instructional diagram for the Tyblume kit showing a 28-day pill blister chart. It includes circles numbered 1 to 28 arranged in four weekly rows with arrows indicating the pill-taking sequence. A purple color indicates placebo pills from days 22 to 28. The chart has space for placing day-of-week labels and includes note instructions for starting and aligning the chart with the user's pill schedule.*

FDA Label Image

Principal Display Panel (Kit Carton)

Tyblume kit packaging label for Levonorgestrel and Ethinyl Estradiol tablets, strength 0.1 mg/0.02 mg. The label indicates a kit containing 1 blister card of 28 chewable tablets, with 21 white active tablets and 7 peach inert tablets. Distributed by Exeltis USA, Inc., the packaging features the brand and generic names, dosage form, and manufacturer details, along with barcodes and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.